{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:01:51Z","timestamp":1795111311749,"version":"4.10.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:00:00Z","timestamp":1793577600000},"content-version":"vor","delay-in-days":116,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014091","name":"AstraZeneca Pharma Poland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-026-02980-0","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:14:13Z","timestamp":1783599253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AI-driven diagnostic algorithm enhances early detection of paroxysmal nocturnal hemoglobinuria in real-world settings"],"prefix":"10.1038","volume":"9","author":[{"given":"Robert","family":"Dewor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal J.","family":"Dabrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Wi\u0119cek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Amtma\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Woszczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miko\u0142aj","family":"Mr\u00f3z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Turczyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"W\u0119glarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szymon","family":"Fornagiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Krzanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Stach-Nowosiad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sobas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Szukalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miros\u0142aw","family":"Markiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Kot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Gala-B\u0142\u0105dzi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Br\u00f3\u017c","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Piszcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Leo\u0144czuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Homenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Laso\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Meryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Jurczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Konopelko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Bator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Marciniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Dudzi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Dubiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Lis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"2980_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.htct.2020.06.006","volume":"43","author":"RD Cancado","year":"2021","unstructured":"Cancado, R. D. et al. Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. Hematol. Transfus. Cell Ther. 43, 341\u2013348 (2021).","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"2980_CR2","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00277-023-05269-4","volume":"102","author":"D Dingli","year":"2023","unstructured":"Dingli, D. et al. Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry. Ann. Hematol. 102, 1637\u20131644 (2023).","journal-title":"Ann. Hematol."},{"key":"2980_CR3","doi-asserted-by":"publisher","unstructured":"Bravo-Perez, C., Guarnera, L., Williams, N. D. & Visconte, V. Paroxysmal nocturnal hemoglobinuria: Biology and treatment. Medicina (Kaunas) 59, https:\/\/doi.org\/10.3390\/medicina59091612 (2023).","DOI":"10.3390\/medicina59091612"},{"key":"2980_CR4","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1172\/JCI74747","volume":"124","author":"W Shen","year":"2014","unstructured":"Shen, W. et al. Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria. J. Clin. Invest 124, 4529\u20134538 (2014).","journal-title":"J. Clin. Invest"},{"key":"2980_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03283-x","volume":"19","author":"J Spychalska","year":"2024","unstructured":"Spychalska, J. et al. Diagnostic landscape of first-time cytometric screening for paroxysmal nocturnal hemoglobinuria in Poland in 2013-2022. Orphanet J. Rare Dis. 19, 271 (2024).","journal-title":"Orphanet J. Rare Dis."},{"key":"2980_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1182\/asheducation-2016.1.208","volume":"2016","author":"CJ Parker","year":"2016","unstructured":"Parker, C. J. Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria. Hematology 2016, 208\u2013216 (2016).","journal-title":"Hematology"},{"key":"2980_CR7","doi-asserted-by":"publisher","unstructured":"Fattizzo, B., Serpenti, F., Giannotta, J. A. & Barcellini, W. Difficult cases of paroxysmal nocturnal hemoglobinuria: Diagnosis and therapeutic novelties. J. Clin. Med. 10, https:\/\/doi.org\/10.3390\/jcm10050948 (2021).","DOI":"10.3390\/jcm10050948"},{"key":"2980_CR8","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.18553\/jmcp.2020.26.12-b.s3","volume":"26","author":"M Bektas","year":"2020","unstructured":"Bektas, M., Copley-Merriman, C., Khan, S., Sarda, S. P. & Shammo, J. M. Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology. J. Managed Care Specialty Pharm. 26, S3\u2013S8 (2020).","journal-title":"J. Managed Care Specialty Pharm."},{"key":"2980_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/cyto.b.21608","volume":"94","author":"AE Dezern","year":"2018","unstructured":"Dezern, A. E. & Borowitz, M. J. ICCS\/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 1 - clinical utility. Cytom. B Clin. Cytom. 94, 16\u201322 (2018).","journal-title":"Cytom. B Clin. Cytom."},{"key":"2980_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/cyto.b.21609","volume":"94","author":"A Illingworth","year":"2018","unstructured":"Illingworth, A., Marinov, I., Sutherland, D. R., Wagner-Ballon, O. & DelVecchio, L. ICCS\/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 3 - data analysis, reporting and case studies. Cytom. B Clin. Cytom. 94, 49\u201366 (2018).","journal-title":"Cytom. B Clin. Cytom."},{"key":"2980_CR11","doi-asserted-by":"publisher","unstructured":"Visibelli, A., Roncaglia, B., Spiga, O. & Santucci, A. The impact of artificial intelligence in the odyssey of rare diseases. Biomedicines 11, https:\/\/doi.org\/10.3390\/biomedicines11030887 (2023).","DOI":"10.3390\/biomedicines11030887"},{"key":"2980_CR12","first-page":"e46860","volume":"15","author":"S Abdallah","year":"2023","unstructured":"Abdallah, S. et al. The impact of artificial intelligence on optimizing diagnosis and treatment plans for rare genetic disorders. Cureus 15, e46860 (2023).","journal-title":"Cureus"},{"key":"2980_CR13","doi-asserted-by":"publisher","unstructured":"Michalski, A. A. et al. Supporting the diagnosis of fabry disease using a natural language processing-based approach. J. Clin. Med. 12, https:\/\/doi.org\/10.3390\/jcm12103599 (2023).","DOI":"10.3390\/jcm12103599"},{"key":"2980_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-02150-3","volume":"16","author":"JL Jefferies","year":"2021","unstructured":"Jefferies, J. L. et al. A new approach to identifying patients with elevated risk for Fabry disease using a machine learning algorithm. Orphanet J. Rare Dis. 16, 518 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"2980_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01374-z","volume":"15","author":"C Faviez","year":"2020","unstructured":"Faviez, C. et al. Diagnosis support systems for rare diseases: a scoping review. Orphanet J. Rare Dis. 15, 94 (2020).","journal-title":"Orphanet J. Rare Dis."},{"key":"2980_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01424-6","volume":"15","author":"J Schaefer","year":"2020","unstructured":"Schaefer, J., Lehne, M., Schepers, J., Prasser, F. & Thun, S. The use of machine learning in rare diseases: a scoping review. Orphanet J. Rare Dis. 15, 145 (2020).","journal-title":"Orphanet J. Rare Dis."},{"key":"2980_CR17","doi-asserted-by":"publisher","first-page":"e60665","DOI":"10.2196\/60665","volume":"12","author":"L Cao","year":"2024","unstructured":"Cao, L., Sun, J. & Cross, A. An automatic and end-to-end system for rare disease knowledge graph construction based on ontology-enhanced large language models: Development study. JMIR Med Inf. 12, e60665 (2024).","journal-title":"JMIR Med Inf."},{"key":"2980_CR18","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1111\/cts.13619","volume":"16","author":"M Wojtara","year":"2023","unstructured":"Wojtara, M., Rana, E., Rahman, T., Khanna, P. & Singh, H. Artificial intelligence in rare disease diagnosis and treatment. Clin. Transl. Sci. 16, 2106\u20132111 (2023).","journal-title":"Clin. Transl. Sci."},{"key":"2980_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1040-6","volume":"14","author":"S Ronicke","year":"2019","unstructured":"Ronicke, S. et al. Can a decision support system accelerate rare disease diagnosis? Evaluating the potential impact of Ada DX in a retrospective study. Orphanet J. Rare Dis. 14, 69 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"2980_CR20","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1038\/s41431-021-00928-4","volume":"29","author":"N Hurvitz","year":"2021","unstructured":"Hurvitz, N., Azmanov, H., Kesler, A. & Ilan, Y. Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases. Eur. J. Hum. Genet 29, 1485\u20131490 (2021).","journal-title":"Eur. J. Hum. Genet"},{"key":"2980_CR21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/bjh.18343","volume":"198","author":"SY Chai","year":"2022","unstructured":"Chai, S. Y., Hayat, A. & Flaherty, G. T. Integrating artificial intelligence into haematology training and practice: Opportunities, threats and proposed solutions. Br. J. Haematol. 198, 807\u2013811 (2022).","journal-title":"Br. J. Haematol."},{"key":"2980_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/bjh.16915","volume":"192","author":"R Shouval","year":"2021","unstructured":"Shouval, R., Fein, J. A., Savani, B., Mohty, M. & Nagler, A. Machine learning and artificial intelligence in haematology. Br. J. Haematol. 192, 239\u2013250 (2021).","journal-title":"Br. J. Haematol."},{"key":"2980_CR23","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1182\/blood-2019-122405","volume":"134","author":"V Bob\u00e9e","year":"2019","unstructured":"Bob\u00e9e, V. et al. Combining Gene Expression Profiling and Artificial Intelligence to Diagnose B-Cell Non-Hodgkin Lymphoma. Blood 134, 1476\u20131476 (2019).","journal-title":"Blood"},{"key":"2980_CR24","first-page":"2100","volume":"141","author":"F Gutierrez-Rodrigues","year":"2023","unstructured":"Gutierrez-Rodrigues, F. et al. Differential diagnosis of bone marrow failure syndromes guided by machine learning. Blood 141, 2100\u20132113 (2023).","journal-title":"Blood"},{"key":"2980_CR25","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood.2022019444","volume":"141","author":"AG Kulasekararaj","year":"2023","unstructured":"Kulasekararaj, A. G. AI for AA: machine learning makes an entry. Blood 141, 2040\u20132042 (2023).","journal-title":"Blood"},{"key":"2980_CR26","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1182\/blood.2020005488","volume":"136","author":"Y Nagata","year":"2020","unstructured":"Nagata, Y. et al. Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes. Blood 136, 2249\u20132262 (2020).","journal-title":"Blood"},{"key":"2980_CR27","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1182\/blood.V128.22.3193.3193","volume":"128","author":"A Nazha","year":"2016","unstructured":"Nazha, A. et al. Using machine intelligence algorithms to develop a geno-clinical model to predict responses to hypomethylating agents in myelodysplastic syndromes. Blood 128, 3193\u20133193 (2016).","journal-title":"Blood"},{"key":"2980_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03406-4","volume":"19","author":"A Worker","year":"2024","unstructured":"Worker, A. et al. A machine learning algorithm for the detection of paroxysmal nocturnal haemoglobinuria (PNH) in UK primary care electronic health records. Orphanet J. Rare Dis. 19, 378 (2024).","journal-title":"Orphanet J. Rare Dis."},{"key":"2980_CR29","doi-asserted-by":"publisher","first-page":"e59858","DOI":"10.2196\/59858","volume":"12","author":"K Yamashita","year":"2024","unstructured":"Yamashita, K. et al. Early diagnosis of hereditary angioedema in Japan based on a US medical dataset: Algorithm development and validation. JMIR Med Inf. 12, e59858 (2024).","journal-title":"JMIR Med Inf."},{"key":"2980_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111517","volume":"175","author":"A Tenenbaum","year":"2024","unstructured":"Tenenbaum, A. et al. A machine learning model for early diagnosis of type 1 Gaucher disease using real-life data. J. Clin. Epidemiol. 175, 111517 (2024).","journal-title":"J. Clin. Epidemiol."},{"key":"2980_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.28","volume":"3","author":"A Hill","year":"2017","unstructured":"Hill, A., DeZern, A. E., Kinoshita, T. & Brodsky, R. A. Paroxysmal nocturnal haemoglobinuria. Nat. Rev. Dis. Prim. 3, 17028 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2980_CR32","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3324\/haematol.2013.093161","volume":"99","author":"H Schrezenmeier","year":"2014","unstructured":"Schrezenmeier, H. et al. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica 99, 922\u2013929 (2014).","journal-title":"Haematologica"},{"key":"2980_CR33","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00277-020-04052-z","volume":"99","author":"H Schrezenmeier","year":"2020","unstructured":"Schrezenmeier, H. et al. Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): Updated analysis from the International PNH Registry. Ann. Hematol. 99, 1505\u20131514 (2020).","journal-title":"Ann. Hematol."},{"key":"2980_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/ejh.14080","volume":"111","author":"L Terriou","year":"2023","unstructured":"Terriou, L. et al. Long-term effectiveness of eculizumab: Data from the International PNH Registry. Eur. J. Haematol. 111, 796\u2013804 (2023).","journal-title":"Eur. J. Haematol."},{"key":"2980_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/ejh.14128","volume":"112","author":"C Rich","year":"2024","unstructured":"Rich, C., Wilson, K., Olsen, J., Pedersen, M. & Frederiksen, H. The disease burden of paroxysmal nocturnal hemoglobinuria in Denmark: Epidemiology, survival, healthcare resource utilization, costs, treatment gaps, and labor market attachment. Eur. J. Haematol. 112, 412\u2013423 (2024).","journal-title":"Eur. J. Haematol."},{"key":"2980_CR36","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1182\/blood-2019-125867","volume":"134","author":"JJ Jalbert","year":"2019","unstructured":"Jalbert, J. J., Chaudhari, U., Zhang, H., Weyne, J. & Shammo, J. M. Epidemiology of PNH and real-world treatment patterns following an incident PNH diagnosis in the US. Blood 134, 3407\u20133407 (2019).","journal-title":"Blood"},{"key":"2980_CR37","doi-asserted-by":"publisher","unstructured":"Rho, H., Yang, K., Chow, S. & Patriquin, C. Striving for excellence in paroxysmal nocturnal hemoglobinuria in Canada: The EPIC program. J. Rare Dis. 4, https:\/\/doi.org\/10.1007\/s44162-025-00087-w (2025).","DOI":"10.1007\/s44162-025-00087-w"},{"key":"2980_CR38","unstructured":"Mitchell, R., Salkeld, E., Chisolm, S., Clark, M. & Shammo, J. Path to Diagnosis of Paroxysmal Nocturnal Hemoglobinuria: The Results of an Exploratory Study Conducted by the Aplastic Anemia and MDS International Foundation and the National Organization for Rare Disorders Utilizing an Internet-Based Survey. 1, 1001 (2017)."},{"key":"2980_CR39","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","volume":"106","author":"C Parker","year":"2005","unstructured":"Parker, C. et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106, 3699\u20133709 (2005).","journal-title":"Blood"},{"key":"2980_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/cyto.b.20525","volume":"78","author":"MJ Borowitz","year":"2010","unstructured":"Borowitz, M. J. et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytom. B Clin. Cytom. 78, 211\u2013230 (2010).","journal-title":"Cytom. B Clin. Cytom."},{"key":"2980_CR41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s11739-023-03517-z","volume":"19","author":"S Leoni","year":"2024","unstructured":"Leoni, S. et al. Deciphering cytopenias in internal medicine: a single-center observational study. Intern Emerg. Med 19, 661\u2013668 (2024).","journal-title":"Intern Emerg. Med"},{"key":"2980_CR42","doi-asserted-by":"publisher","unstructured":"Romano, A. D. et al. Molecular aspects and treatment of iron deficiency in the elderly. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21113821 (2020).","DOI":"10.3390\/ijms21113821"},{"key":"2980_CR43","doi-asserted-by":"publisher","DOI":"10.1177\/10760296231213073","volume":"30","author":"D Clayton","year":"2024","unstructured":"Clayton, D. et al. Treatment patterns and healthcare resource utilization of patients with paroxysmal nocturnal hemoglobinuria: A retrospective claims data analysis. Clin. Appl Thromb. Hemost. 30, 10760296231213073 (2024).","journal-title":"Clin. Appl Thromb. Hemost."},{"key":"2980_CR44","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","volume":"124","author":"RA Brodsky","year":"2014","unstructured":"Brodsky, R. A. Paroxysmal nocturnal hemoglobinuria. Blood 124, 2804\u20132811 (2014).","journal-title":"Blood"},{"key":"2980_CR45","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.3747\/co.25.4018","volume":"25","author":"SA Wong","year":"2018","unstructured":"Wong, S. A., Dalal, B. I. & Leitch, H. A. Paroxysmal nocturnal hemoglobinuria testing in patients with myelodysplastic syndrome in clinical practice-frequency and indications. Curr. Oncol. 25, e391\u2013e397 (2018).","journal-title":"Curr. Oncol."},{"key":"2980_CR46","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/bjh.19048","volume":"203","author":"K Ishiyama","year":"2023","unstructured":"Ishiyama, K. et al. A longitudinal analysis of paroxysmal nocturnal haemoglobinuria-type cells in patients with bone marrow failure: Results of a prospective multi-centre study in Japan. Br. J. Haematol. 203, 468\u2013476 (2023).","journal-title":"Br. J. Haematol."},{"key":"2980_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1426-2","volume":"17","author":"CJ Kelly","year":"2019","unstructured":"Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G. & King, D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med 17, 195 (2019).","journal-title":"BMC Med"},{"key":"2980_CR48","first-page":"301","volume":"4","author":"J Spychalska","year":"2013","unstructured":"Spychalska, J. & Brojer, E. Paroxysmal nocturnal hemoglobinuria \u2014 pathophysiology, classification and modern diagnostics. Hematol. Clin. Pract. 4, 301\u2013320 (2013).","journal-title":"Hematol. Clin. Pract."},{"key":"2980_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v085.i12","volume":"85","author":"M Drami\u0144ski","year":"2018","unstructured":"Drami\u0144ski, M. & Koronacki, J. rmcfs: An R Package for Monte Carlo feature selection and interdependency discovery. J. Stat. Softw. 85, 1\u201328 (2018).","journal-title":"J. Stat. Softw."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02980-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02980-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02980-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:04:20Z","timestamp":1793624660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02980-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2980"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-02980-0","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.D. is an employee and shareholder of AstraZeneca. P.D. is an employee of AstraZeneca. K.L., M.D., G.B. are the shareholders of Saventic Health. M.J.D., G.B., P.T. received honoraria from Saventic Health. A.G.-B. received paid expert testimony from AstraZeneca. L.W., W.A., W.W., M.M.roz, A.R., A.L., A.M., A.J., M.K., A.B., K.M., M.D., K.L. are employees of Saventic Health. G.H., P.W., S.F., J.K., K.S.-N., M.S., L.S., M.M., S.K., S.B., J.P., N.L., W.H. declare no competing financial or non-financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"834"}}